Nanocatalyst-Mediated Chemodynamic Tumor Therapy

• Published in: Advanced healthcare materials Vol. 11; no. 2; p. e2101971
• Main Authors: Zhang, Lu, Li, Chu-Xin, Wan, Shuang-Shuang, Zhang, Xian-Zheng
• Format: Journal Article
• Language: English
• Published: Germany 01.01.2022
• Subjects: Antineoplastic Agents - chemistry; Antineoplastic Agents - pharmacology; Antineoplastic Agents - therapeutic use; Catalysis; Cell Line, Tumor; Humans; Hydrogen Peroxide; Nanoparticles - chemistry; Neoplasms - drug therapy; Photochemotherapy; Tumor Microenvironment; tumor microenvironments; Fenton nanocatalysts; chemodynamic therapy; tumor therapy; hydroxyl radicals
• ISSN: 2192-2659
• DOI: 10.1002/adhm.202101971

Traditional tumor treatments, including chemotherapy, radiotherapy, photodynamic therapy, and photothermal therapy, are developed and used to treat different types of cancer. Recently, chemodynamic therapy (CDT) has been emerged as a novel cancer therapeutic strategy. CDT utilizes Fenton or Fenton-like reaction to generate highly cytotoxic hydroxyl radicals (•OH) from endogenous hydrogen peroxide (H O ) to kill cancer cells, which displays promising therapeutic potentials for tumor treatment. However, the low catalytic efficiency and off-target side effects of Fenton reaction limit the biomedical application of CDT. In this regard, various strategies are implemented to potentiate CDT against tumor, including retrofitting the tumor microenvironment (e.g., increasing H O level, decreasing reductive substances, and reducing pH), enhancing the catalytic efficiency of nanocatalysts, and other strategies. This review aims to summarize the development of CDT and summarize these recent progresses of nanocatalyst-mediated CDT for antitumor application. The future development trend and challenges of CDT are also discussed.